Evotec AG Reports Results of First Quarter 2014
14 mai 2014 01h44 HE
|
Evotec AG
CONTINUING TO ACCELERATE INNOVATION EFFICIENCY STRATEGY IN NEWLY SEGMENTED BUSINESS FORMATION
HAMBURG, Germany, May 14, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX)...
Evotec to Report First Quarter 2014 Results on 14 May 2014
07 mai 2014 07h40 HE
|
Evotec AG
HAMBURG, Germany, May 7, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) will report its financial results for the first quarter of 2014 on Wednesday, 14 May...
Evotec and Eternygen Enter Collaboration to Identify and Develop Novel Metabolic Disease Therapy
06 mai 2014 01h38 HE
|
Evotec AG
BERLIN and HAMBURG, Germany, May 6, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Eternygen GmbH, a privately owned biopharmaceutical company, today announced a...
Evotec Receives First Milestone in Roche Biomarker Collaboration
24 avr. 2014 01h37 HE
|
Evotec AG
HAMBURG, Germany, April 24, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced the successful achievement of a milestone in its biomarker...
Evotec and Debiopharm Group(TM) to Collaborate on Development of New Treatment for Cancer
02 avr. 2014 01h39 HE
|
Evotec AG
Innovative partnership based on one of Evotec's Target X projects
Evotec and Debiopharm to share discovery and development efforts
LAUSANNE, Switzerland and HAMBURG, Germany, April 2,...
Evotec and Convergence Form Integrated Pain Alliance
31 mars 2014 01h40 HE
|
Evotec AG
HAMBURG, Germany, March 31, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it has entered into a research alliance with Panion Ltd, a subsidiary...
Evotec FY 2013: Execute on Innovate to Create Value
25 mars 2014 02h58 HE
|
Evotec AG
HAMBURG, Germany, March 25, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced its financial results for the fiscal year ended 31 December 2013, which are...
Evotec Acquires Bionamics GmbH to Accelerate "EVT Innovate" Strategy
24 mars 2014 02h40 HE
|
Evotec AG
Expanding discovery pipeline with portfolio of projects especially in Multiple Sclerosis and CNS
Appointment of Dr Timm Jessen as "EVP Business Development EVT Innovate" to further enhance...
Evotec AG: Fiscal Year 2013 Results Presentation on 25 March 2014
18 mars 2014 09h28 HE
|
Evotec AG
HAMBURG, Germany, March 18, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for 2013 on Tuesday, 25 March 2014.
The...
Evotec and Yale University to Collaborate on Cancer Therapy
17 déc. 2013 01h40 HE
|
Evotec AG
First collaboration within open innovation alliance with Yale University
Collaborative effort will explore novel mechanisms, targets and compounds that have the potential to interfere with...